Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinoma. - Xu C; Lin ZQ; Wang YZ; Shen JX; Li WF; Zhou GQ; Yang KB; Wen MY; Zhang YN; Shen LF; Yang KY; Chen XZ; et al. (Med (New York, N.Y.), 2026)